Advertisement
NNRTIs in Development
- A Clinical Overview of Capravirine (Regularly Updated)
To read PDF, click here.
From U.S. National Institutes of Health
- Peering in the Pipeline (Summer 2009)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
- Two NNRTIs in Early Development Show Promising Results (August 7, 2008)
From Project Inform
- TMC278 Nanosuspension Found Long-Acting, Well-Tolerated in First Trial in HIV-Uninfected Subjects (August 5, 2008)
In The XVII International AIDS Conference, from The Body PRO
- TMC278 (Rilpivirine) Efficacy, Toxicity and Pharmacokinetics (July 24, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
- An Alternative NNRTI, TMC278, Progresses in Development (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- NNRTIs in Development (March 30, 2006)
An overview from Edwin DeJesus, M.D.
From The Body
Antiretroviral Therapy
Antiretroviral Therapy
E-Mail
Share